| Literature DB >> 29379995 |
Nabil El Massri1, Karen M Cullen1, Sebastian Stefani1, Cécile Moro2, Napoleon Torres2, Alim-Louis Benabid2, John Mitrofanis3.
Abstract
In this study, we examined the cellular distribution of encephalopsin (opsin 3; OPN3) expression in the striatum of non-human primates. In addition, because of our long standing interest in Parkinson's disease and neuroprotection, we examined whether parkinsonian (MPTP; 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) insult and/or photobiomodulation (670 nm) had any impact on encephalopsin expression in this key area of the basal ganglia. Striatal sections of control naïve monkeys, together with those that were either MPTP- and/or photobiomodulation-treated were processed for immunohistochemistry. Our results revealed two populations of striatal interneurones that expressed encephalopsin, one of which was the giant, choline acetyltransferase-containing, cholinergic interneurones. The other population had smaller somata and was not cholinergic. Neither cell group expressed the calcium-binding protein, parvalbumin. There was also rich encephalopsin expression in a set of terminals forming striosome-like patches across the striatum. Finally, we found that neither parkinsonian (MPTP) insult nor photobiomodulation had any effect on encephalopsin expression in the striatum. In summary, our results revealed an extensive network of encephalopsin containing structures throughout the striatum, indicating that external light is in a position to influence a range of striatal activities at both the interneurone and striosome level.Entities:
Keywords: Acetylcholine; Caudate; MPTP; OPN3; Photobiomodulation; Putamen
Mesh:
Substances:
Year: 2018 PMID: 29379995 DOI: 10.1007/s00221-018-5191-9
Source DB: PubMed Journal: Exp Brain Res ISSN: 0014-4819 Impact factor: 1.972